Vanguard Global Advisers’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.9M Sell
97,284
-5,712
-6% -$113K ﹤0.01% 1294
2026
Q1
$1.98M Buy
+102,996
New +$2.03M ﹤0.01% 1199

Other funds holding SBRA

Vanguard Global Advisers's SBRA Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Sabra Healthcare REIT (SBRA) stake by 5.5% in Q2 2026, selling an estimated $113K and leaving 97,284 shares worth $1.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1294.

Vanguard Global Advisers first reported a position in SBRA in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.98M in Q1 2026. 453 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Vanguard Global Advisers held 97,284 shares of Sabra Healthcare REIT worth $1.9M as of Q2 2026.
  • Vanguard Global Advisers sold 5,712 Sabra Healthcare REIT shares in Q2 2026, an estimated $113K.
  • Sabra Healthcare REIT made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #1294 holding.
  • Vanguard Global Advisers first reported a position in Sabra Healthcare REIT in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Sabra Healthcare REIT position peaked at $1.98M in Q1 2026.
  • 453 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.